Dopamine hypotheses of several psychiatric disorders are based upon the clinical benefits
of drugs affecting dopamine transporter or receptors, and have prompted intensive …

Psychostimulant addiction is a heritable substance use disorder; however its genetic basis is
almost entirely unknown. Quantitative trait locus (QTL) mapping in mice offers a …

Methamphetamine (METH) use can provoke psychotic reactions requiring immediate
treatment, namely METH-induced psychosis. Although the distinction between METH …

Objective: There is considerable evidence to suggest that the abuse of illicit drugs,
particularly cannabis and methamphetamine, has aetiological roles in the pathogenesis of …

Although it has been initially synthesized for therapeutic purposes and currently FDA-
approved and prescribed for obesity, attention-deficit/hyperactivity disorder, narcolepsy and …

Genetic susceptibility to methamphetamine use disorder is poorly understood. No twin or
adequately powered genome-wide association studies (GWASs) have been conducted …

Abuse of amphetamine-type stimulants (ATS) has become a global public health problem.
ATS causes severe neurotoxicity, which could lead to addiction and could induce psychotic …

The clinical presentation, course and treatment of methamphetamine (METH)-associated
psychosis (MAP) are similar to that observed in schizophrenia (SCZ) and subsequently MAP …

Aims To explore the clinical features of methamphetamine‐induced paranoia (MIP) and
associations between MIP and a genetic polymorphism in dopamine β‐hydroxylase (DBH …

Methods: Demographic, MA use, and diagnostic data for 782 MA users were obtained by
using the Semi-Structured Assessment for Drug Dependence and Alcoholism—Thai version …